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We study the regulating mechanism of p53 on the properties of cell cycle dynamics in the light of
the proposed model of interacting p53 and cell cycle networks via p53. Irradiation (IR) introduce
to p53 compel p53 dynamics to suffer different phases, namely oscillating and oscillation death
(stabilized) phases. The IR induced p53 dynamics undergo collapse of oscillation with collapse time
∆t which depends on IR strength. The stress p53 via IR drive cell cycle molecular species MPF
and cyclin dynamics to different states, manely, oscillation death, oscillations of periods, chaotic
and sustain oscillation in their bifurcation diagram. We predict that there could be a critical ∆tc
induced by p53 via IRc, where, if ∆t〈∆tc the cell cycle may come back to normal state, otherwise
it will go to cell cycle arrest (apoptosis).
I. INTRODUCTION
p53 is well known for its abnormally long stability in
response to the stress available against genomic integrity
[1]. It conglomerated with its negative inhibitor MDM2
in the nucleus due to their strong interaction [2]. When
the cell is in stress condition (due to irradiation, stress
inducer molecule etc), p53 concentration level rises which
leads to cell cycle arrest until repair or doctoring takes
place of the impaired DNA. If the repair is not success-
ful the system move towards the apoptosis [3–6]. The
transcriptional ability of the p53 is kept under controlled
level at normal state due to its negative feedback inter-
action with MDM2 [7]. The hyperbolized concentration
of MMD2 helps in degradation of the p53 protein be-
cause of its E3-ligase activity, causing adherence of ubiq-
uitin to the lysine rich C-terminal of the p53 molecule
[8–10]. Introduction of stress in the system is sensed by
the activation of ARF protein, initially situated in nu-
cleolar region in the form of nucleophosmin shifts to the
nucleoplasm in its independent and active cast, to mark
MDM2 for its degradation, thus assisting the p53 stabil-
ity [11–13]. Triggering of p53 in response to stress leads
to the expression of several downstream genes apart from
the MDM2.
p21 protein is one of the most important proteins which
is found to be expressed due to p53 accumulation in the
cell [14]. p53 acts as a transcription factor for p21. It
is also reported that p21 expression is directly propor-
tional to the level of p53 in the system [15]. The role of
p21 in controlling G1 phase checkpoint has been widely
studied but its role in controlling G2 phase checkpoint is
comapratively less studied [16–18]. The G2 phase check-
point interuption leads to the disruption of cell cycle that
leads to halt mitosis [14]. The cyclin-cdk interaction
leads to the formation of MPF (Maturation Promoting
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Factor) [19]. The formation of MPF is very important
for transition of G2 phase to mitosis phase [20]. The
p21 protein is reported as antagonist for the formation
of MPF . Several experimental results suggests that p21
directly interacts with cdk and also with cyclin leading
to the inhibition of both cdk as well as cyclin [21]. It is
also reported that the interaction of cdk and p21 causes
to halt in DNA replication [20, 22].
Cyclin, in cell cycle process, is an important protein
which interacts with cyclin dependent kinases and forms
MPF . The MPF is responsible for the activation of
pRb (Retinoblastoma protein), and helps the liberation
of transcription factor E2F from its inhibitory. This
E2F maintains the expression profile of genes required to
ingress the S-phase of the cell division cycle [23–25]. Fur-
ther, it is reported by several experimental results that
p21 can directly interact with MPF and forms complex
and then dissociate [16, 18]. Hence, p53 can able to cross
talk with MPF and cyclin through p21.
We focus in this work to study and find out the be-
haviour of different molecular species which are actively
involved in the checking of cell cycle at G2 phase regu-
lated by p53. We proposed an integrated model of p53
and cell cycle network to find out the impact of p53 regu-
lator on cell cycle via p21 protein. We organized our work
as follows. We explained our proposed model in section
II. The results of the large scale simulation of the model
is given in section III with discussion. The conclusion
based on our results is provided in section IV.
II. MODEL OF CELL CYCLE REGULATED BY
p53
We present a model which brings together p53 −
MDM2 regulatory network [26] and cell cyle [27] via p21
protein (Fig. 1) in the light of various theoretical and ex-
perimental reports. The model is described briefly as fol-
lows. The main component of p53 −MDM2 regulatory
network is the feedback loop between p53 and MDM2
[26]. p53 and MDM2 interact to form p53 − MDM2
2FIG. 1: The schematic diagram of interaction of p53-Mdm2 reaction network cell cycle oscillator.
complex with a rate constant k17 [26], followed by disso-
ciation of the complex to its respective components with
a rate costant k18 [28, 29]. The transcription rate of
MDM2 gene to its mRNA (MDM2−mRNA) is takes
place with rate constant k20, followed by translation of
MDM2 − mRNA to MDM2 with a rate constant k22
[26, 30] and its (MDM2−mRNA) self-degradation with
a rate constant k21 [31]. The ubiqiutination of MDM2
protein occurs with rate constant k23. The p53 synthesis
is taken placed with a rate constant k16, and gets ubiqui-
tinized at the rate constant k19 [30]. The DNA damage
in system is introduced via irradiation with an estimated
rate constant of k24 [26]. The repair of the DNA damage
is then occured at a rate constant k25 [32, 33]. The acti-
vation of ARF due to DNA damage takes place at a rate
constant k26[26]. Further, this activated form of ARF
interact with MDM2 protein and forms ARF −MDM2
complex with a rate constant k27 [34]. The degradation
of ARF protein is reported to occur at a rate constant
k28 [35]. ARF based degradation of the MDM2 takes
place by getting targeted to the complex via proteosome
recognition with a much faster rate constant k29 than
individual degradation rates [36]. The p53, being a tran-
scription promoting factor for many of the proteins, also
transcribes the gene responsible for the manufacture of
p21 protein with a rate constant k30 as presumed by the
approximations made to attain the appropriate oscilla-
tions and arrests [14, 37, 38].
The p21 protein is capable of making complex with
the cell division promoting factor MPF with a rate con-
stant k31 [16, 18] with respect to the amount of con-
cerned molecules present in the system [19]. Then the
inhibition of MPF , or more appropriately G2 associated
Cyclin − Cdk complex, by p21 is approximated with a
rate constant k32 [37, 39]. p21 then gets degraded by
the virtue of its half life in the system with a rate con-
stant k33 [18, 23]. The Cyclin is assumed to translate at
the rate constant k1[40]. Further, ubiquitin dependent
Cyclin degradation or protease independent degradation
of the Cyclin is reported to happen at a rate constant
k∗ [41]. The degradation of the Cyclin due to effect of
protease activation during cyclin accumulation and in-
teraction between inactive form of MPF with Cyclin
takes place with a rate constant k4 [27]. Formation of
activated form of MPF (M) occurs due to interaction
of cyclin with inactive MPF (M∗) with a rate constant
k∗∗[27, 42–44]. Further this activated form of MPF (M)
converts to inactivated form (M∗)with a rate constant
k∗∗∗ [42, 44]. The activated form of MPF (M) interact
with inactive protease(X∗) to generate activated form of
protease (X) with a rate constant k∗∗∗∗ [27, 45, 46]. The
generation of activated form of cyclin protease (X) oc-
curs due to interaction of cyclin protease with inactiveX∗
with a rate k∗∗∗∗∗[27, 42]. The activated form of protease
(X) can convert into inactive form (X∗) with a rate con-
stant k∗∗∗∗∗∗[27, 44]. The lists of molecular species and
biochemical reaction channels involved in this proposed
model are listed in Table 1 and Table 2 respectively.
The biochemical reaction network shown in Fig. 1 are
represented by the twenty five reaction channels listed
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FIG. 2: Plot shows the variation in the concentration and
oscillatory pattern of p53 protein due to the effect of various
exposure of IR i.e (0,0.1,1,5,10).
in Table 2, which are participated by thirteen molecular
species (Table 1) defined by a vector at any instant of
time t, x(t) = {x1(t), x2(t), . . . , xN (t)}
T , where, T is the
transpose of the vector and N = 13. The variables are
the concentrations of the molecular species. The time
evolution of these variables can be translated from the
twenty five reaction channels into the following set of
nonlinear ordinary differential equations (ODE) based on
Mass action law of chemical kinetics,
dx1
dt
= k1 −
k2x1x3
k3 + x1
− k4x1
dx2
dt
=
k5(1− x2)
x6 + (1− x2)
−
k7x2
k8x2
− k31x12x2
dx3
dt
=
k9(1 − x3)
k10 + (1− x3)
−
k11x3
k12 + x3
dx4
dt
= k16 + k18x6 − k17x4x5
dx5
dt
= k22x7 + k19x6 + k18x6 − k23x5 − k17x5x4
−k27x5x8
dx6
dt
= k17x4x5 − k18x6 − k19x6
dx7
dt
= k20x4 − k21x7
dx8
dt
= k26x11 + k29x9 − k27x5x8 − k28x8
dx9
dt
= k27x5x8 − k29x9
dx10
dt
= −k24x10
dx11
dt
= k24x10 − k25x11
dx12
dt
= k30x4 − k31x2x12 + k32x13 − k33x12
dx13
dt
= k31x12x2 − k32x13
where, the expressions for M∗ and X∗ in the Fig. 1 are
given by, M∗=1-x10 and X
∗=1-x11. The set of coupled
ODEs can be solved using Runge Kutta method of stan-
dard numerical integration algorithm [47].
III. RESULTS AND DISCUSSION
We numerically simulate the proposed model and the
results demonstrate new phenomena in bifurcation dia-
gram which may be significant to correlate with various
experimental situations. The interaction of p53 regula-
tory network and cell cycle network highlights different
form of signal processing between unidentical networks
which could be the way of regulating one another. We
study the complicated way of this interaction in order
to understand some of the basic mechanisms of network
interaction.
A. Dynamics of p53 driven by irradiation
We first present the spatio-temporal behaviour of p53
upon exposure of irradation in Fig. 2. The p53 dynamics
maintains minimum concentration level at IR = 0 (nor-
mal condition). As IR dose increases p53 start show-
ing damped oscillatory behaviour (Fig. 2 second and
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FIG. 3: Plot for showing the impact of IR on p53 maxima. Different p53 maxima observed at different values of IR with respect
to time. The p53 maxima verses IR dose is shown at left hand side inset and also IR dose verses time is shown in right hand
inset.
third panels) indicating stressed behaviour of p53. The
increase in IR dose induce increase in time to attain sta-
bility of p53 dynamics (amplitude death) indicating in-
crease in unstability of p53 dynamics (Fig. 2 third panel).
This could be due to the fact that the increase in IR dose
may cause high DNA damage leading to more stress in
p53.
However, if the IR dose is comparatively strong (IR =
5), the damage within the DNA is also high which may
cause the collapse of the p53 oscillatory behaviour (Fig.
2 fourth panel) and then repaired back the DNA dam-
age to come back to p53 oscillatory condition. We also
found that the time of collapse (∆t) increases as IR dose
increases (Fig. 2 fifth panel) and it becomes difficult to
repair back the DNA damage. In general p53 will collapse
forever and will not be recovered back if ∆t→∞ (prob-
ably case of apoptosis). However, in real situation, one
probably can define a critical ∆tc such that, if ∆t〈∆tc,
p53 could come back after DNA repair, and otherwise it
will go to apoptosis. Nevertheless, it is very difficult to
find out this ∆tc.
B. Phase diagram of p53 compeled by IR
We simulate the maxima of p53 amplitudes after re-
moving the transients as a function of IR (Fig. 3) to
capture the different phases namely oscillation and oscil-
lation death regimes. The behaviour of ∆t as a function
of IR follows the functional form ∆t = A
B+e−IR
with the
values of A = 6778 and B = 0.00887 (fitting values of
the function to the data) (Fig. 3 inset). The separa-
tion between two phases oscillation death and oscillating
regimes are clearly visible after the IR ∼ 3.45 and ∆t
increases as IR increases.
Generally as ∆t→∞ when IR→∞, but numerically
we approximately found that after IR = Rc ∼ 11 ∆t
become ∆tc ∼ 79 hours and becomes constant (Fig. 3
inset). This means that for any ∆t〈∆tc, the p53 can able
to recover back to normal stable state by repairing DNA
damage, otherwise, the system can’t able to come back
to normal state, but will go to apoptosis.
C. Bifurcation in Cyclin regulated by p53
Since cell cycle and p53 regulatory networks are inter-
acted through p21 (Fig. 1), the temporal behaviour of
cyclin can be regulated by p53 via IR and p21. When
IR = 0, the two networks work in normal condition,
leaving p53 dynamics at low level (stabilized state) (Fig.
2 upper panel) and sustain oscillation in cyclin dynam-
ics (Fig. 4 upper left panel). As IR increases, p53
will get activated through DNA damage giving oscilla-
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FIG. 4: Plot shows the variation in the oscillatory pattern of cyclin due to the effect of various exposure of IR i.e (0,0.1,1,5,10)
at left side panels and their corresponding bifurcation diagram are shown at right panels.
tory behaviour affecting the dynamics of cyclin. When
IR = 0.1, the cyclin dynamics shows chaotic behaviour
upto t = 145 hours, and then the dynamics becomes sus-
tain oscillation (Fig. 4 second left panel and upper right
panel). The chaotic behaviour in cyclin dynamics could
due to the sudden activation in p53 dynamics due to IR
irradiation.
Now as IR increases (IR = 0.5), we get various sit-
uations in the cyclin dynamics, namely, the emergence
of period two (for t ∼ [10 − 40] hours), period 3 (for
t ∼ [40 − 85] hours), chaotic regime (for t ∼ [85 − 175]
hours) and sustain oscillation regime (for t〉175 hours)
(Fig. 4 second right upper panel). Further, as IR in-
creases the emergence of oscillation death regime started
to exist in the cyclin dynamics (Fig. 4 fourth right
panel onwards) and the oscillation death regime become
larger. Further increase in IR compels the period 2 and
3 regimes to vanish after some value of IR (IR〉9) and
the chaotic regime becomes larger.
The perturbation induced by p53 through IR to the
cyclin via p21 clearly induces cyclin dynamics to various
states shown by the bifurcation diagram (Fig. 4 right
panels). We also notice that as one decreases or increases
to cross over to sustain oscillation, the state just before
it is chaotic regime. The emergence of oscillation death
regime starts from IR〉3 and then switch to sustain os-
cillation after sometime. This oscillation death regime
corresponds to the collapse time due to strong sudden
DNA damage. Once the DNA damage is recovered it
comes back to sustain oscillation. If the IR is very large
then oscillation death regime is large enough that DNA
damage can not be repaired back halting the cell cycle
permanantly and goes to apoptosis.
D. Dynamics of MPF regulated by p53
We present the temporal behaviour of MPF regulated
by p53 as a function of IR (Fig. 5) which induce at differ-
ent states in MPF shown by bifurcation diagrams. The
impact upon the MPF due to p53 via IR is not a direct
phenomena but through p21 molecule in the network.
Various studies reported that p21 directly interact with
cyclin dependent kinases, which has very important role
in the formation of maturation promoting factor (MPF).
The interaction of p21 with cdk leads to less availability
of cdk due to the formation of MPF . Moreover, various
experimental results also reported that p21 directly in-
teracts with MPF [16, 18]. It is observed that a IR = 0,
the MPF dynamics shows sustain oscillatory behaviour
showing no impact of p53. Further, as IR dose increases
the oscillatory behaviour of MPF is abruptly changed
inducing different states of MPF as we obtained in the
case of cyclin. The increase in IR induce different states
oscillation death, period 1, 2, 3, chaotic and sustain os-
cillation regimes indicated by the bifurcation diagram for
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FIG. 5: Plot shows the variation in the oscillatory pattern of MPF(Maturation Promoting Factor) due to the effect of various
exposure of IR i.e (0,0.1,1,5,10) at left side panels and their corresponding bifurcation diagram are shown at right panels.
various IR values. Moreover, as IR increases the width
of oscillation death [16] regime also increases and if IR
is not strong enough the DNA can able to repair back
otherwise the system will go to apoptosis.
E. Bifurcation in MPF and Cyclin
We study the regulation of cell cycle dynamics by p53
via IR. The maxima values of MPF (MPFM ) and cy-
clin (CycM ) as a function of IR are calculated for a range
of time in the range [0, 50] hours (Fig. 6). It is observed
that for low IR dose, MPFM exhibits chaotic behaviour.
Howeover, if IR dose is comparatively high, MPFM be-
comes almost constant. If the value of IR is moderate,
period 1, 2, 3 etc are exhibited in the bifurcation dia-
gram. This indicates that MPFM is p53 dependent via
IR and p53 controls theMPFM behaviour in the system.
Similarly, one can also observe the IR dependent max-
ima of cyclin CycM in the bifurcation diagram (Fig. 6
lower panel). The moderate values of IR induce differ-
ent periods in CycM . Excess values of IR shows different
behaviour in CycM .
IV. CONCLUSION
We study the way how p53, one of the largest hubs
in cellular network, regulates and controls cell cycle dy-
namics. We studied the behaviour of different molecules
which are highly involved in the checking of cell cycle at
G2 phase driven by p53 via IR. The simulation results
of the model provided us to understand the biological
phenomenon and mechanism of cell cycle arrest due to
DNA damage faced by the cell due to the irradiation.
The results we got are closely in agreement with the pre-
vious experimental reports [16, 17]. Our study suggested
that the temporal dynamics of molecular species involved
in cell cycle, considered in the model, are controlled by
p53. The role of p21 protein in the delay of G2 phase
was considered as a cross-talk between p53 regulatory
network and cell cycle. The sudden irradiation to the
system with high dose induce collapse of the system due
to DNA damage, leading to cell cycle arrest. The cell
cycle is resumed again to normal situation by repairing
back the DNA damage. Moreover, the time of recovery
from cell cycle arrest and then resumption of oscillation
depends on the amount of dose of IR exposed to the
system.
During the process of regulation of cell cyle by p53
via IR we observed the emergence of different periods
(1, 2, 3 etc) in the bifurcation diagram of oscillatory dy-
namics of cell cycle variables (MPFM and CycM ) which
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FIG. 6: Plot shows the impact of various IR dose on MPF
maxima (at upper panel) as well as Cyclin maxima (at lower
panel).
may have various information of certain biological signif-
icance. Further, the dynamics of these variables switched
to various states, namely, chaotic, oscillation death (sta-
bilized state), bifurcating to various periods of oscillation
and sustain oscillation states during the process of time
evolution. These states could be the different phases of
the variables to self-recover back to its normal condition
from the sudden stress given to the system. However,
how do these complicated states are used by the system
dynamics when the system is perturbed need to be in-
vestigated further.
The study also demonstrates the mechanism of cell cy-
cle arrest induced by perturbed p53 via IR indicated by
collapse of the oscillation (oscillation death) for certain
interval of time (∆t). This collapse time is a function of
strength of the perturbation imparted to the system. Our
study shows that there is a minimum value of IR = Rc,
below which the system comes back to its normal state,
otherwise the system will go to apoptosis. Our findings
will probably be useful for the further study on the im-
pact of p53 on cell cycle checking at G2 phase and related
dynamics.
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Appendix A TABLES OF MOLECULAR
SPECIES AND BIOCHEMICAL REACTION
CHANNELS OF THE MODEL
9TABLE I: Table 1: List of molecular species
S.No. Species Name Description Notation
1. Cyclin Unbounded Cyclin protein x1
2. MPF Maturation promotion factor x2
3. Cyclin −
Protease
Unbounded Cyclin Protease x3
4. p53 Unbounded p53 protein x4
5. Mdm2 Unbounded Mdm2 protein x4
6. Mdm2 p53 Mdm2 with p53 complex x6
7. Mdm2 mRNA Mdm2 messenger mRNA x7
8. ARF Unbounded ARF protein x8
9. ARF Mdm2 ARF Mdm2 complex x9
10. IR Irradiation x10
11. DamDNA Damaged DNA x11
12. p21 p21 protein x12
13. p21 M p21 and M complex x13
10
Table 2 List of chemical reaction, rate constant and their values
S.No. Biochemical
reaction
Description Rate Constant Values of Rate
Constant
Ref.
1 φ
k1−→ x1 Synthesis of Cyclin k1 0.000416667 ×
10−2sec−1
[27, 48,
49]
2 x1
k
∗
−→ φ Decay of Cyclin k∗〈x1〉, where, k
∗ = k2x1x3
k3+x1
k2 =
0.004166667sec−1, k3 =
0.02sec−1
[27, 41]
3 x1
k4−→ φ Cyclin decay k4〈x1〉 0.0000167sec
−1 [27]
4 φ
k
∗∗
−→ x2 Creation of MPF k
∗∗, where, k∗∗ =
k5(1−x2)
k6+(1−x2)
, k5 =
k14x1
k13+x1
k6 = 0.01, k13 =
0.5, k14 = 0.00sec
−1
[16, 27,
44]
5 x2
k
∗∗∗
−→ φ Decay of MPF k∗∗∗〈x2〉, where, k
∗∗∗ =
k7x2
k8x2
k7 =
0.0025sec−1, k8 =
0.01sec−1
[16, 42,
44]
6 x2 + x12
k31−→ x13 Formation of MPF p21 com-
plex
k31〈x2〉〈x12〉 0.0001mol
−1sec−1 [16, 18,
19]
7 φ
k7−→ x3 Activation of protease molecule k
∗∗∗∗, where, k∗∗∗∗ =
k9(1−x3)
k10+(1−x3)
, k9 = x2k15
k10 = 0.01, k15 =
0.001667
[27, 45,
46]
8 x3
k
∗∗∗∗∗
−→ φ Inactivation of protease
molecule
k∗∗∗∗∗〈x3〉, where, k
∗∗∗∗∗ =
k11x3
k12+x3
k11 =
0.0008333, k12 = 0.01
[27, 44]
9 φ
k16−→ x4 creation of p53 k16 0.078 [26, 29,
30]
10 x4 + x5
k17−→ x6 synthesis of p53 MDM2 com-
plex
k17〈x4〉〈x5〉 1.155 ×
10−3mol−1sec−1
[26, 29]
11 x6
k18−→ x4 + x5 Dissociation of p53 MDM2
complex
k18〈x6〉 1.155 × 10
−5sec−1 [26, 28,
29]
12 x6
k19−→ x5 ubiquitination of p53 k19〈x6〉 8.25× 10
−4sec−1 [26, 29,
30]
13 x4
k20−→ x4 + x7 creation of MDM2 mRNA k20〈x4〉 1.0× 10
−4sec−1 [26, 29,
31]
14 x7
k21−→ φ decay of MDM2 mRNA k21〈x7〉 1.0× 10
−4sec−1 [26, 29,
31]
15 x7
k22−→ x5 + x7 synthesis of MDM2 k22〈x7〉 4.95× 10
−4sec−1 [26, 29,
30]
15 x5
k23−→ φ decay of MDM2 k23〈x5〉 4.33× 10
−4sec−1 [26, 29,
30]
16 x10
k24−→ x11 creation of DNA damage k24〈x10〉 1.0sec
−1 [26, 32]
17 x11
k25−→ φ recovery of damaged DNA k25〈x11〉 2.0× 10
−5sec−1 [26, 33]
18 x11
k26−→ x8 Activation of ARF k26〈x11〉 3.3× 10
−5sec−1 [26]
19 x5 + x8
k27−→ x9 synthesis of MDM2 ARF com-
plex
k27〈x5〉〈x8〉 0.01mol
−1sec−1 [26, 34]
20 x8
k28−→ φ decay of ARF k28〈x9〉〈x8〉 0.001sec
−1 [26, 35]
21 x9
k29−→ x8 degradation of MDM2 k29〈x9〉 0.001sec
−1 [26, 36]
22 x4
k30−→ x4 + x12 synthesis of p21 k30〈x4〉 0.001sec
−1 [14, 37,
38]
23 x2 + x12
k30−→ x13 synthesis of p21 MPF complex k31〈x4〉 0.0001sec
−1 [14, 37,
38]
24 x13
k32−→ x12 dissociation of p21 MPF com-
plex
k32〈x13〉 0.002sec
−1 [16, 18,
37]
25 x12
k33−→ φ decay of p21 complex k33〈x12〉 0.005sec
−1 [16, 37]
